Antiviral research
Overview of gene editing strategies against HBV.
Zak T Janetzki, Laura C McCoullough, Peter A Revill, Margaret Littlejohn
Published: 202610.1016/j.antiviral.2026.106355
Abstract
254 million people currently live with chronic hepatitis B virus (HBV) infection, with over 1 million deaths annually due to complications such as cirrhosis and hepatocellular carcinoma. Although current direct-acting antivirals suppress HBV replicat…
Preview only. Read the full abstract at the source